Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...
Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.
The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...
The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, ...
Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...
Your doctor will help you decide which form, pill or injection, of Wegovy is best for you. It may depend on your medical history, which dosing schedule fits your lifestyle better, and how comfortable ...
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.
On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results